EMR Q2 2026 Earnings Call Summary | Stock Taper
Logo
EMR

EMR — Emerson Electric Co.

NYSE


Q2 2026 Earnings Call Summary

May 5, 2026

Summary of Emerson's Q2 2026 Earnings Call

1. Key Financial Results and Metrics

  • Adjusted Earnings Per Share (EPS): $1.54, a 4% year-over-year increase, near the top end of guidance.
  • Underlying Sales Growth: 0.5%, impacted by a 1-point decline due to Middle East conflict; excluding this, growth was approximately 3%.
  • Adjusted Segment EBITDA Margin: 27.6%, exceeding expectations and benefiting from favorable mix and cost reductions.
  • Annual Contract Value (ACV): Grew 9% year-over-year, ending at $1.64 billion.
  • Cash Flow: $694 million in Q2, with a margin of 15%; on track for approximately 10% growth in full-year cash flow.
  • Backlog: Increased 9% year-over-year to $8.2 billion.

2. Strategic Updates and Business Highlights

  • End Market Demand: Strong demand, particularly in Software & Systems and Test & Measurement, with underlying orders growing 5%.
  • New Board Member: Jennifer Newstead, previously of Apple and Meta, was elected to the Board, enhancing governance and expertise.
  • Project Wins: Significant contracts awarded, including $450 million from growth verticals like power, life sciences, and LNG.
  • AI Integration: Emerson is embedding AI into its software solutions, with a notable deployment for Aramco, enhancing operational capabilities.

3. Forward Guidance and Outlook

  • Sales Growth Guidance: Updated to 4.5% for the year, with underlying growth expected at 3%.
  • Adjusted EPS Guidance: Raised to $6.45 to $6.55 per share.
  • Q3 Expectations: Anticipating sales growth of approximately 5.5% and adjusted EPS of $1.65 to $1.70.
  • Long-term Outlook: Confidence in second-half plans based on order momentum and backlog visibility.

4. Bad News, Challenges, or Points of Concern

  • Middle East Conflict Impact: The ongoing conflict caused a 1-point impact on sales; operational disruptions were significant, with 47 customer sites affected.
  • China Market Weakness: Declining demand in China, particularly in the chemical sector, led to a reassessment of growth expectations for the region.
  • Software Contract Renewal Dynamics: Adverse effects on sales growth and margins due to contract renewals, impacting overall performance.
  • Logistics Challenges: Ongoing disruptions in the Strait of Hormuz affecting supply chain and operational capacity.

5. Notable Q&A Insights

  • Rebuild Opportunities: Emerson estimates a $100 million rebuild opportunity in the Middle East, with potential for further growth as infrastructure is restored.
  • China's Decline: The chemical industry in China remains overcapacitated, contributing to a downward revision in growth expectations.
  • MRO Activity: Despite oil price increases, no significant delays in maintenance, repair, and operations (MRO) activities were noted, with expectations for continued demand.
  • AI Adoption: While customer interest in AI solutions is strong, significant revenue impacts from these products are not expected until 2027 and beyond.

This summary encapsulates the key points from Emerson's Q2 2026 earnings call, highlighting financial performance, strategic initiatives, guidance, challenges, and insights from the Q&A session.